The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
2020 ◽
Vol 106
(1)
◽
pp. 167-173
◽
2015 ◽
Vol 93
(3)
◽
pp. E297
2003 ◽
Vol 179
(5)
◽
pp. 345-351
◽
2011 ◽
Vol 104
(1)
◽
pp. 68-70
◽
2014 ◽
Vol 90
(1)
◽
pp. S547
Keyword(s):
2013 ◽
Vol 87
(2)
◽
pp. S466
Keyword(s):
2018 ◽
Vol 100
(3)
◽
pp. 639-646
◽
Keyword(s):
2013 ◽
Vol 87
(3)
◽
pp. 479-486
◽
2020 ◽
Vol 108
(3)
◽
pp. e108-e109
2010 ◽
Vol 28
(15_suppl)
◽
pp. e16010-e16010
◽